Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biodesix (BDSX) Shares Outstanding (2019 - 2025)

Biodesix's Shares Outstanding history spans 7 years, with the latest figure at $8.3 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 13.44% year-over-year to $8.3 million; the TTM value through Dec 2025 reached $8.3 million, up 13.44%, while the annual FY2025 figure was $8.3 million, 13.44% up from the prior year.
  • Shares Outstanding reached $8.3 million in Q4 2025 per BDSX's latest filing, up from $8.0 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $88.3 million in Q3 2023 to a low of $27020.0 in Q3 2021.
  • Average Shares Outstanding over 5 years is $29.1 million, with a median of $17.5 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: surged 9799536.36% in 2021, then crashed 93.8% in 2023.
  • A 5-year view of Shares Outstanding shows it stood at $30.8 million in 2021, then surged by 152.08% to $77.6 million in 2022, then plummeted by 93.8% to $4.8 million in 2023, then soared by 51.18% to $7.3 million in 2024, then increased by 13.44% to $8.3 million in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Shares Outstanding are $8.3 million (Q4 2025), $8.0 million (Q3 2025), and $7.3 million (Q2 2025).